Synovics Pharmaceuticals Stock Alpha and Beta Analysis

SYVC Stock  USD 0.0001  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Synovics Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Synovics Pharmaceuticals over a specified time horizon. Remember, high Synovics Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Synovics Pharmaceuticals' market risk premium analysis include:
Beta
0.0
Alpha
0.0
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although Synovics Pharmaceuticals alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Synovics Pharmaceuticals did 0.00  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Synovics Pharmaceuticals stock's relative risk over its benchmark. Synovics Pharmaceuticals has a beta of 0.00  . The returns on DOW JONES INDUSTRIAL and Synovics Pharmaceuticals are completely uncorrelated. At present, Synovics Pharmaceuticals' Price Fair Value is projected to increase slightly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 6.1 M, whereas Book Value Per Share is forecasted to decline to 0.23.

Enterprise Value

6.13 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Synovics Pharmaceuticals Backtesting, Synovics Pharmaceuticals Valuation, Synovics Pharmaceuticals Correlation, Synovics Pharmaceuticals Hype Analysis, Synovics Pharmaceuticals Volatility, Synovics Pharmaceuticals History and analyze Synovics Pharmaceuticals Performance.
For information on how to trade Synovics Stock refer to our How to Trade Synovics Stock guide.

Synovics Pharmaceuticals Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Synovics Pharmaceuticals market risk premium is the additional return an investor will receive from holding Synovics Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Synovics Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Synovics Pharmaceuticals' performance over market.
α0.00   β0.00

Synovics Pharmaceuticals expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Synovics Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Synovics Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Synovics Pharmaceuticals Market Price Analysis

Market price analysis indicators help investors to evaluate how Synovics Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Synovics Pharmaceuticals shares will generate the highest return on investment. By understating and applying Synovics Pharmaceuticals stock market price indicators, traders can identify Synovics Pharmaceuticals position entry and exit signals to maximize returns.

Synovics Pharmaceuticals Return and Market Media

The median price of Synovics Pharmaceuticals for the period between Mon, Sep 29, 2025 and Sun, Dec 28, 2025 is 1.0E-4 with a coefficient of variation of 0.0. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.0, and mean deviation of 0.0. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Joby, Archer Aviation Stocks Take Off After Cryptic Tweet From Tesla - Barrons
10/06/2025
2
Stock Market Today Stock-Market Rebound Evaporates as AI Fears Resurface - The Wall Street Journal
11/20/2025
3
Pound Rising Ahead of Crucial UK Budget - Bloomberg.com
11/26/2025

About Synovics Pharmaceuticals Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Synovics or other stocks. Alpha measures the amount that position in Synovics Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2010 2011 2024 2025 (projected)
Days Sales Outstanding347.0953.7261.77111.3
PTB Ratio4.4E-54.71E-44.24E-44.45E-4
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Synovics Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Synovics Pharmaceuticals' short interest history, or implied volatility extrapolated from Synovics Pharmaceuticals options trading.

Build Portfolio with Synovics Pharmaceuticals

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Synovics Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Synovics Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Synovics Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Synovics Pharmaceuticals Stock:
Synovics Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Synovics Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Synovics Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...